Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Wushuang Du"'
Autor:
James G. Herman, Wushuang Du, Lidong Wang, Shunchang Jiao, Aiai Gao, Lirong Zhang, Mingzhou Guo
Publikováno v:
Cancer Science
Wnt, PI3K‐Akt‐mTOR, and NF‐κB pathways were reported to be involved in DNA damage repair (DDR). DDR‐deficient cancers become critically dependent on backup DNA repair pathways. Neuritin 1 (NRN1) is reported to be involved in PI3K‐Akt‐mTO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee4182ef7b7528e5ba70a4f3f708bac
https://doi.org/10.1111/cas.14917
https://doi.org/10.1111/cas.14917
Autor:
Jia Song, Chan Gao, Wushuang Du, Zhichao Yue, Juan Zhang, Guangying Chen, Danyang Sun, Yi Hu, Junxun Ma, Zhaozhen Wu, Chun Han, Yuanyu Qian, Xiaoyan Li, Xuan Zheng, Pengfei Cui, Shangli Cai, Shixue Chen, Jinliang Wang, Xiaochen Zhao
Publikováno v:
Cancer Immunology, Immunotherapy
Background Evidence for the efficacy of immunotherapy in biliary tract cancer (BTC) is limited and unsatisfactory. Methods Chinese BTC patients receiving a PD-1 inhibitor with chemotherapy, PD-1 inhibitor monotherapy or chemotherapy alone were retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::303b112e62590a80dde0d500b8071511
https://doi.org/10.1007/s00262-019-02386-w
https://doi.org/10.1007/s00262-019-02386-w
Autor:
Zhichao Yue, Wushuang Du, Juan Zhang, Jia Song, Chan Gao, Shixue Chen, Jinliang Wang, Danyang Sun, Guangying Chen, Junxun Ma, Zhaozhen Wu, Chun Han, Pengfei Cui, Shangli Cai, Xuan Zheng, Yuanyu Qian, Xiaoyan Li, Yi Hu
Publikováno v:
Cancer immunology, immunotherapy : CII. 69(3)
Immune checkpoint inhibitors (ICIs) represent a major breakthrough for cancer treatment. However, evidence regarding the use of ICIs in pancreatic cancer (PC) remained scarce. To assess the efficacy and safety of ICIs plus chemotherapy, patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cc55293dd989a41c22c13efd5f88880
https://pubmed.ncbi.nlm.nih.gov/31897660
https://pubmed.ncbi.nlm.nih.gov/31897660
Autor:
Yi Hu, Danyang Sun, Guangying Chen, Xiaoyan Li, Lijie Wang, Sujie Zhang, Junxun Ma, Jinliang Wang, Wushuang Du, Fan Zhang, Pengfei Cui
Publikováno v:
Therapeutics and clinical risk management. 14
Danyang Sun,* Junxun Ma,* Jinliang Wang, Fan Zhang, Lijie Wang, Sujie Zhang, Guangying Chen, Xiaoyan Li, Wushuang Du, Pengfei Cui, Yi Hu Department of Oncology, Chinese PLA General Hospital, Beijing, China *These authors contributed equally to this w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cea283b87e92f39b259fc2cc935c3ab0
https://pubmed.ncbi.nlm.nih.gov/30254451
https://pubmed.ncbi.nlm.nih.gov/30254451
Autor:
Wushuang, Du, Shuofeng, Hu, Shangli, Cai, Yu, Wang, Liangliang, Wu, Danyang, Sun, Shunchang, Jiao, Yi, Hu
Publikováno v:
Discovery medicine. 25(140)
Immunotherapy against malignant tumors has shown considerable clinical efficacy, especially agents targeting the programmed death 1 (PD-1) pathway. In this study, we set out to dynamically determine the relationships between clinical benefit and chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5493321df00eed09f9c570898dd17079
https://pubmed.ncbi.nlm.nih.gov/30021101
https://pubmed.ncbi.nlm.nih.gov/30021101
Autor:
Jia Song, Yi Hu, Danyang Sun, Yuanyu Qian, Shixue Chen, Wushuang Du, Xiaoyan Li, Guangying Chen, Jinliang Wang, Pengfei Cui, Shangli Cai, Zhaozhen Wu, Xuan Zheng, Juan Zhang, Chun Han, Zhichao Yue, Junxun Ma
Publikováno v:
Journal of Clinical Oncology. 37:e14103-e14103
e14103 Background: Pancreatic cancer (PC) is a highly lethal disease and characterized by a strong resistance to current radiotherapy and chemotherapy. As PC has the presence of a microenvironment filled with immunosuppressive mediators and a dense s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3663e3c82cdefa033b02a359c6adaf1
https://doi.org/10.1200/jco.2019.37.15_suppl.e14103
https://doi.org/10.1200/jco.2019.37.15_suppl.e14103
Autor:
Guangying Chen, Wushuang Du, Zhaozhen Wu, Zhichao Yue, Juan Zhang, Xuan Zheng, Yi Hu, Shixue Chen, Pengfei Cui, Jinliang Wang, Yuanyu Qian, Xiaoyan Li, Junxun Ma, Shangli Cai, Xiaochen Zhao, Danyang Sun, Chun Han, Jia Song
Publikováno v:
Journal of Clinical Oncology. 37:e14100-e14100
e14100 Background: Biliary tract cancer (BTC) is highly aggressive with poor prognosis and few treatment options following progression on gemcitabine-based chemotherapy. Disappointing results from clinical trials for refractory BTC highlight the need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fdf292cb0400acf98eac70fcaf44d7b
https://doi.org/10.1200/jco.2019.37.15_suppl.e14100
https://doi.org/10.1200/jco.2019.37.15_suppl.e14100
Autor:
Yi Hu, Wushuang Du
Publikováno v:
Journal of Clinical Oncology. 36:e15131-e15131
e15131Background: Immunotherapy against malignant tumors shows outstanding clinical efficacy, especially agents targeting the programmed death 1 (PD-1) pathway. In this study, we intended to dynami...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb4f2aface32144b42cdabe1c8dc70c1
https://doi.org/10.1200/jco.2018.36.15_suppl.e15131
https://doi.org/10.1200/jco.2018.36.15_suppl.e15131